Social Worker-Led Intervention Beneficial in Heart Failure

Share this content:

(HealthDay News) -- A social worker-led palliative care intervention seems beneficial for patients with advanced heart failure at high risk for mortality, according to a study published online April 11 in JAMA Cardiology.

Arden E. O'Donnell, M.P.H., from Boston University School of Social Work, and colleagues compared a social worker-led palliative care intervention with usual care for patients recently hospitalized for management of acute heart failure with risk factors for poor prognosis. Fifty patients were randomized to the intervention or usual care.

The researchers found that 82 percent of the patients had been hospitalized more than once for management of heart failure within 12 months of enrollment. Treating physicians anticipated death within a year for 64 percent of the patients at enrollment; 84 percent of patients predicted their life expectancy to be more than five years. Physician-level documentation of advanced care preferences in the electronic health record was seen for more patients in the intervention versus the control group at six months (65 versus 33 percent). The likelihood of revising their baseline prognostic assessment in a direction consistent with the physician's assessment was also increased for surviving patients allocated to the intervention group (94 versus 26 percent).

"Without an adverse impact on quality of life, prognostic understanding and patient-physician communication regarding goals of care may be enhanced by a focused, social worker-led palliative care intervention that begins in the hospital and continues in the outpatient setting," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »